8-K: UpHealth Announces Trustee Change and Provides Update on NYSE Delisting and Bankruptcy Proceedings

UpHealth has appointed a new trustee for its 6.25% Unsecured Convertible Notes, while also providing updates on its NYSE delisting appeal and the bankruptcy proceedings of its subsidiaries.

Summary

• UpHealth has entered into a Tripartite Agreement on January 11, 2024, to change the trustee for its 6.25% Unsecured Convertible Notes due 2026, with Wilmington Trust, National Association resigning and The Bank of New York Mellon Trust Company, N.A. taking over.
• The change of trustee is effective immediately for the trustee role, but the change for note registrar, custodian, conversion agent, and paying agent roles will be effective ten business days later.
• UpHealth's common stock is currently trading over-the-counter under the symbol UPHL after being suspended from the NYSE due to not meeting the minimum market capitalization requirement of $15,000,000.
• The company has appealed the NYSE delisting and has been granted a hearing on April 17, 2024, where they will present a plan to regain compliance.
• The delisting is stayed pending the hearing and any extension granted by the NYSE.
• Thrasys, a subsidiary of UpHealth, has completed its transition agreements with customers and has ceased operations as of December 28, 2023.
• UpHealth is working on a plan to sell its Cloudbreak subsidiary to pay off its 2026 notes and part of its 2025 notes, and to obtain waivers for defaults under its indentures.
• If the Cloudbreak sale is successful, UpHealth will focus on its profitable subsidiary, TTC Healthcare, which is not in bankruptcy.
• The company acknowledges that if they fail to regain compliance with NYSE listing requirements, their stock could be delisted, negatively impacting the stock price and their ability to raise capital.

Sentiment

Score: 2

Explanation: The document highlights significant financial distress, including delisting from the NYSE, bankruptcy filings of subsidiaries, and substantial doubt about the company's ability to continue as a going concern. While there are some positive steps being taken, the overall outlook is negative.

Positives

• The appointment of a new trustee ensures the continued administration of the 6.25% Unsecured Convertible Notes.
• UpHealth has been granted a hearing to appeal the NYSE delisting, providing an opportunity to regain compliance.
• The completion of Thrasys' transition agreements and cessation of operations will lead to a reduction in administrative expenses.
• The planned sale of Cloudbreak could resolve a significant portion of the company's debt.
• The company has a profitable subsidiary, TTC Healthcare, that is not in bankruptcy and will be the focus of the company if the Cloudbreak sale is successful.

Negatives

• UpHealth's common stock has been suspended from the NYSE and is now trading over-the-counter.
• The company is not in compliance with the NYSE's minimum market capitalization requirement of $15,000,000.
• There is no guarantee that the NYSE will grant the company's request for continued listing.
• The Chapter 11 bankruptcy filings of UpHealth's subsidiaries have triggered defaults under the company's indentures.
• The company acknowledges substantial doubt about its ability to continue as a going concern if the delisting is not reversed.
• The company's stock is trading in a less liquid over-the-counter market.

Risks

• Failure to regain compliance with NYSE listing requirements could lead to delisting, negatively impacting the stock price and the company's ability to raise capital.
• The delisting of the common stock could trigger defaults under the company's indentures, potentially accelerating debt obligations.
• The company's ability to continue as a going concern is in doubt due to the acceleration of debt obligations.
• The sale of Cloudbreak is subject to stockholder approval and may not be completed.
• The company's profitable subsidiary, TTC Healthcare, is owned by a subsidiary in Chapter 11 bankruptcy, which needs to be resolved.
• The over-the-counter market is less liquid and could further depress the trading price of the company's common stock.

Future Outlook

The company is focused on regaining compliance with NYSE listing requirements, completing the sale of Cloudbreak, and focusing on its profitable subsidiary, TTC Healthcare. The company acknowledges that there is no guarantee of success in these efforts and that the company's ability to continue as a going concern is in doubt.

Management Comments

• The company intends to continue to take definitive steps in an effort to evidence compliance with the Market Capitalization Rule and other NYSE continued listing requirements.
• The company believes that advancement on, and completion of, the above-described transactions will result in significant positive market reaction and an increase in both the trading price of our Common Stock and our market capitalization such that we will evidence full compliance with the Market Capitalization Rule.

Industry Context

The healthcare technology industry is facing increased scrutiny and challenges, with companies needing to demonstrate profitability and sustainable growth. UpHealth's struggles with delisting and bankruptcy highlight the risks associated with rapid expansion and debt financing in this sector.

Comparison to Industry Standards

• Many healthcare technology companies are focused on achieving profitability and positive cash flow, which UpHealth is attempting to do by focusing on TTC Healthcare.
• The delisting from the NYSE is a significant negative event, as most comparable companies in the sector are listed on major exchanges.
• The bankruptcy filings of UpHealth's subsidiaries are unusual for companies of this size and indicate significant financial distress.
• The planned sale of Cloudbreak to pay down debt is a common strategy for companies facing financial difficulties, but the success of this strategy is not guaranteed.

Legal Proceedings

• UpHealth's common stock is subject to delisting proceedings by the NYSE.
• UpHealth Holdings, Thrasys, and Behavioral Health Services, LLC have filed for Chapter 11 bankruptcy.

Stakeholder Impact

• Shareholders face the risk of further decline in the stock price and potential delisting.
• Employees may experience uncertainty due to the company's financial difficulties and restructuring.
• Customers of Thrasys have transitioned to new service providers.
• Creditors face the risk of not being fully repaid due to the company's debt obligations and bankruptcy filings.

Next Steps

• UpHealth will present its plan to regain compliance with NYSE listing requirements at the hearing on April 17, 2024.
• The company will seek stockholder approval for the sale of Cloudbreak.
• UpHealth will work to complete the sale of Cloudbreak and use the proceeds to pay down debt.
• The company will focus on its profitable subsidiary, TTC Healthcare, if the Cloudbreak sale is successful.

Key Dates

Keywords

delisting, NYSE, trustee, convertible notes, bankruptcy, market capitalization, Cloudbreak, TTC Healthcare, Thrasys, over-the-counter